Hepatitis C - Clinical outcome and diagnosis

JK Science

Volumn 7, Issue 3, 2005, Pages 129-132

  Berry, Vandana ^a   Arora, Rajeev ^a   Paul, Priya ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HUMAN; INFECTION RATE; INFECTION RISK; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CANCER; LIVER FIBROSIS; NONHUMAN; OUTCOMES RESEARCH; REVIEW; SCREENING TEST; SYMPTOMATOLOGY; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 28244457410     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Zucker SD, Goessing W, Gollan JL. Intracellular transport of small hydrophobic compounds by the hepatocyte. Semin Liver Dis 1996; 16: 159-67.
2. Banker PD. Viral hepatitis. Ind J Med Sci 2003; 57: 461-68.
3. Conte D, Fraquelli M, Prati D et al. Prevalence and clinical worse of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission on a cohort of 15, 250 pregnant women. Hepatology 2000; 31: 751-55.
4. Banker DD, Desai P, Brawner TA et al. Hepatitis delta virus infection in Bombay. Trans Roy Soc Trop Med Hyg 1992; 86: 424-25.
5. Kuo G, Choo QL, Aher HJ. An assay for circulating antibodies to a major etiologic virus of non-A non-B viral hepatitis. Science 1989; 244: 362-64.
6. Abraham P, John JT. Hepatitis C. A review with particular reference to the Indian scenario. Ind J Med Microbiol 1995; 13: 5-14.
7. Gosavi MS, Shah SK, Shah SR et al. Prvevalence of hepatitis C virus (HCV) infection in Mumbai. Indian J Med Sci 1997; 51: 378-85.
8. Palotsky JM. Diagnostic tests for hepatitis C. J hepatol 1999; 31(Suppl1): 71-79.
9. Laucer GM, Walker BD. Hepatitis C Virus Infection. N Engl J Med 2001; 345: 41-52.
10. Centres for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C Virus infection and HCV related chronic disease. Morb Mortal Wkly Rep 1998; 47(RR-19): 1-39.
11. David GI. Hepatitis C Virus genotypes and quasispecies. Am J Med 1999; 707: 218-68.
12. Bendinelli M, Pistello M, Maggi F et al. Blood borne hepatitis viruses: Hepatitis B,C,D aid G viruses and TT virus 2000. Clinical virology manual, 3rd ed. ASM Press, Washington DC p 306-37.
13. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatits. Science 1989; 244: 362-64.
14. Gretch DR. Diagnostic tests for Hepatitis C. Hepatology 1997; 26: 435-75.
15. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to hepatitis C virus. Hepatology 1992; 15: 310-53.
16. National Institutes of Health Consensus Development Conference Panel. Management of hepatitis C. Hepatology 1997; 26: 2S-10S.
17. Pawlotsky JM. Diagnostic tests for hepatitis. CJ Hepatol 1999; 31: 71-79.
18. Thio CL, Nolt KR, Astemborski J et al. Screening for hepatitis C virus in human immunodeficiency virus infected individuals. J Clin Mircobiol 2000; 38: 575-77.
19. Richter S. Lab Assays for detection and management of hepatitis C virus infection. J Clin Microbiol 2002; 40: 4407-12.